Life Biosciences
2 stories
-
healthSilicon Valley's Billionaire Bets on Cellular Rejuvenation Enter First Human Trial
Life Biosciences doses first patient in a landmark epigenetic reprogramming trial, as tech titans pivot from software fortunes to radical longevity science amid a backdrop of prior clinical failures.
-
healthLife Biosciences Administers First Human Gene Therapy to Reverse Cellular Aging
Boston-based Life Biosciences has initiated the first human trial of ER-100, a gene therapy using OSK factors to rejuvenate cells and treat optic neuropathies like glaucoma.